Published May 10, 2022
| Version v1
Report
Open
Mass drug administration for malaria during emergencies, periods of health service disruption, or epidemics of febrile illness
Authors/Creators
- 1. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Description
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.6.2 MDA for burden reduction in emergency settings” of the WHO Guidelines for malaria, 3 June 2022.
Files
Sayre-et-all-2021-mda-for-malaria-during-emergencies.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:dc930e7f896ed4c04b9b2776dd4556f9
|
1.2 MB | Preview Download |